ATC
ALT icon

Argent Trust Co’s Altimmune ALT Stock Holding History

Argent Trust Co’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,000
Closed -$61K – 513
2022
Q1 		$61K Hold
10,000
– – ﹤0.01% 534
2021
Q4 		$92K Hold
10,000
– – 0.01% 540
2021
Q3 		$113K Hold
10,000
– – 0.01% 519
2021
Q2 		$99K Buy
+10,000
New +$137K 0.01% 507

Other funds holding ALT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Argent Trust Co's ALT Position: Q2 2022 in Review

Argent Trust Co sold out of Altimmune (ALT) in Q2 2022, closing a stake of 10,000 shares — an estimated $61K sold.

Argent Trust Co first reported a position in ALT in Q2 2021 and held it in 4 quarters. The position peaked at $113K in Q3 2021. 110 funds tracked by Wall St. Rank hold ALT as of Q2 2022.

  • Argent Trust Co reported no remaining Altimmune position as of Q2 2022 after selling out during the quarter.
  • Argent Trust Co sold 10,000 Altimmune shares in Q2 2022, an estimated $61K.
  • Argent Trust Co first reported a position in Altimmune in Q2 2021 and held it in 4 quarters.
  • Argent Trust Co's Altimmune position peaked at $113K in Q3 2021.
  • 110 funds tracked by Wall St. Rank held Altimmune as of Q2 2022.

Based on Argent Trust Co's 13F filing for Q2 2022, filed 11 Aug 2022.